12-55321076-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001005182.2(OR6C1):c.477G>A(p.Met159Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000479 in 1,461,378 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001005182.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR6C1 | NM_001005182.2 | c.477G>A | p.Met159Ile | missense_variant | 2/2 | ENST00000642104.1 | NP_001005182.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR6C1 | ENST00000642104.1 | c.477G>A | p.Met159Ile | missense_variant | 2/2 | NM_001005182.2 | ENSP00000492978 | P1 | ||
OR6C1 | ENST00000379668.3 | c.477G>A | p.Met159Ile | missense_variant | 1/1 | ENSP00000368990 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000200 AC: 5AN: 250374Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 135324
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461378Hom.: 0 Cov.: 38 AF XY: 0.00000688 AC XY: 5AN XY: 726996
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 01, 2024 | The c.477G>A (p.M159I) alteration is located in exon 1 (coding exon 1) of the OR6C1 gene. This alteration results from a G to A substitution at nucleotide position 477, causing the methionine (M) at amino acid position 159 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at